New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:31 EDTARGSArgos data shows disease eradication potential, says JMP Securities
JMP Securities believes that immunological data from patients on Argos' AGS-004 indicates that the drug can affect latent reservoirs of HIV virus. The firm views this as a key step in virus eradication, and it thinks the data suggest the drug can be effectively combined with PD-1/PDL-1 inhibitors in HIV and oncology. It reiterates an Outperform rating on the stock.
News For ARGS From The Last 14 Days
Check below for free stories on ARGS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ARGS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use